Sentry Data Systems Buys Agilum Healthcare

The acquisition is intended to add new capabilities to Sentry's current software-as-a-service (SaaS) DataNext healthcare enterprise management solutions, which provides technology and data analytics solutions that help healthcare organizations manage costs, compliance, and outcomes. The proprietary solutions provide a comprehensive financial analytics platform for pharmacy, supply chain, revenue integrity, and margin optimization to more than 76 million patients and more than 7,000 hospitals, clinics, integrated delivery networks (IDNs), and pharmacies.

Agilum Healthcare Intelligence provides enterprise business intelligence solutions that help health systems improve operating performance through increased transparency and access to actionable financial information. Merging Agilum’s capabilities will those of Sentry will provide customers with a superior range of solutions for managing costs, improving revenues, and delivering high-value care across all departments and service lines, and especially US Federal 340B management solutions for hospital pharmacies and other covered entities, as well as their contract pharmacies.

“Bringing to market the financial analytic and reporting solutions that meet our customers' business challenges remains central to our strategy,” said Travis Leonardi, CEO and Founder of Sentry. “In Agilum, we see a highly compatible organization with great potential to strengthen and augment our proprietary platform. This acquisition is the next step in delivering on Sentry's core vision to make available the data analytics and business intelligence critical for managing the entire healthcare enterprise.”

“Together with Sentry, we're going to help our customers transform their business operations to thrive in today's challenging, competitive environment, where value-based purchasing and other cost pressures put their margins at risk,” said Mark McCurry, CEO of Agilum Healthcare Intelligence. “With the pervasive financial transparency that our solutions provide, health systems will be able to implement world-class business practices to optimize their financial performance, while delivering the highest-quality care.”

The 340B Drug Discount Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices. The intent of the program is to allow covered entities to reach more eligible patients and provide more comprehensive services. Maintaining services and lowering medication costs for patients is consistent with the purpose of the program, which is named for the section authorizing it in the Public Health Service Act (PHSA). It was enacted by the US Congress as part of a larger bill signed into law by President George H.W. Bush.

Related Links:
Sentry Data Systems
Agilum Healthcare Intelligence